Cahill Represents Initial Purchasers in $400 Million Notes Offering for Ortho-Clinical Diagnostics S.A. and Ortho-Clinical Diagnostics, Inc.
Date: 06/11/20
Cahill represented the initial purchasers in connection with a Rule 144A offering of $400,000,000 aggregate principal amount of 7.375% senior notes due 2025 by Ortho-Clinical Diagnostics S.A. and Ortho-Clinical Diagnostics, Inc. Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.